)
Edge12 Dec 2025
Running on Clouds: The Story of On
The story of how a Swiss runner's pursuit of a new running sensation became On, aiming to be the most premium global sportswear brand worldwide.
Daiichi Sankyo Company
Daiichi Sankyo Company (4568) investor relations material
Daiichi Sankyo Company 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.44th Annual J.P. Morgan Healthcare Conference summary12 Jan, 2026
Strategic overview and financial performance
Transitioned from cardiovascular to oncology focus, doubling revenue and tripling profit over five years, driven by ENHERTU and DATROWAY.
FY2025 revenue forecast at 2,100.0 Bn JPY, up 11.3% from FY2024, with 70% generated outside Japan, mainly the US.
Core operating profit projected at 350.0 Bn JPY, a rise of 11.9%.
Four consecutive years of dividend increases, targeting DOE of 8.5% in FY2025 and annual dividend of 78 JPY per share.
New five-year business plan to be announced in April, focusing on sustainable growth and enhanced shareholder returns.
ADC technology and product pipeline
DXd ADC platform recognized as industry-leading, with up to 14 Breakthrough Therapy designations in the US since 2017.
ENHERTU established as standard of care in multiple HER2-positive cancer indications, achieving rapid market leadership and 1573.4 Bn JPY cumulative global net sales since launch.
DATROWAY approved for HR-positive, HER2-negative breast cancer and EGFR-mutated lung cancer, with global net sales exceeding 10 Bn JPY in Q2 FY2025.
New pivotal trials and indications for ENHERTU and DATROWAY expected to drive growth through 2030.
Seven DXd ADCs developed, with several others in late-stage development targeting solid tumors and hematological malignancies.
Clinical and scientific innovation
ENHERTU's first-line HER2-positive metastatic breast cancer indication shows significant survival benefits.
DATROWAY's TROPION-Breast02 trial in triple-negative breast cancer demonstrated improved survival and response rates.
Ongoing investment in immuno-oncology, combining IO agents with ADCs for complementary effects.
Multimodality strategy includes ADCs, medium-sized molecules, nucleic acids, gene therapy, glycoengineering, and mRNA vaccines.
Multiple World ADC Awards in 2025, including Best ADC Platform Technology.
R&D investment impact on profit in next 5 years
Next ADC platform's ENHERTU-like potential
DATROWAY's differentiation in TNBC and lung cancer
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Daiichi Sankyo Company earnings date
Q3 202630 Jan, 2026
Daiichi Sankyo Company
Next Daiichi Sankyo Company earnings date
Q3 202630 Jan, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Daiichi Sankyo Company Limited is a global pharmaceutical company, focusing on the research, development, manufacturing, and marketing of pharmaceutical products. The company operates in the healthcare sector, providing drugs and services in various therapeutic areas, including cardiovascular, oncology, and metabolic disorders, among others. Daiichi Sankyo's approach combines expertise in biologics with advanced research technologies to develop novel therapies and solutions for patients worldwide. The company is headquartered in Tokyo, Japan, and its shares are listed on the Tokyo Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage